The use of EEG in Alzheimer┬┤s disease, with and without scopolamine - A pilot study.

The use of EEG in Alzheimer┬┤s disease, with and without scopolamine - A pilot study.Iceland
AIMS OF THE EEG PROJECT

The primary aim of the project is to validate the accuracy of the qEEG-SPR-method developed by Mentis Cura, Reykjavik in diagnosing causes of cognitive impairment and dementia.

The secondary aim of the project is to collect comparative clinical information from all sites, of various forms of dementia in order to facilitate collaborative research in the future.

An emphasis will be on formal academic research with the participation of one or more PhD students in line with interest at each site.

Snaedal J, Johannesson G.H, Gudmundsson Th. E, Padjak T. H, Johnsen, K. The use of EEG in Alzheimer’s disease, with and without scopolamine – A pilot study. Clin Neurophysiol 2010;121:836-841.


Back
Powered By Zetta